Calcium in PDB 6sm1: Wild Type Immunoglobulin Light Chain (Wt-1)

The structure of Wild Type Immunoglobulin Light Chain (Wt-1), PDB code: 6sm1 was solved by P.Kazman, M.-T.Vielberg, M.D.P.Cendales, L.Hunziger, B.Weber, U.Hegenbart, M.Zacharias, R.Koehler, S.Schoenland, M.Groll, J.Buchner, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	15.00 / 1.55
Space group	P 63 2 2
Cell size a, b, c (Å), α, β, γ (°)	104.500, 104.500, 55.220, 90.00, 90.00, 120.00
R / Rfree (%)	14.2 / 16.5

The binding sites of Calcium atom in the Wild Type Immunoglobulin Light Chain (Wt-1) (pdb code 6sm1). This binding sites where shown within 5.0 Angstroms radius around Calcium atom.
In total only one binding site of Calcium was determined in the Wild Type Immunoglobulin Light Chain (Wt-1), PDB code: 6sm1:

Calcium binding site 1 out of 1 in the Wild Type Immunoglobulin Light Chain (Wt-1)


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 1 of Wild Type Immunoglobulin Light Chain (Wt-1) within 5.0Å range: probe atom residue distance (Å) B Occ A:Ca201 b:41.1 occ:1.00 O A:HOH369 2.2 44.6 1.0 O A:VAL112 2.3 27.6 1.0 O A:GLY114 2.4 53.7 1.0 O A:HOH413 2.4 44.8 1.0 O A:HOH405 2.4 46.6 1.0 OE2 A:GLU87 2.4 28.7 1.0 CD A:GLU87 3.4 32.2 1.0 C A:VAL112 3.5 25.5 1.0 C A:GLY114 3.6 55.7 1.0 OE1 A:GLU87 3.7 40.8 1.0 N A:VAL112 4.1 22.1 1.0 CA A:VAL112 4.2 23.3 1.0 N A:GLY114 4.2 42.1 1.0 O A:HOH336 4.4 49.8 1.0 OXT A:GLY114 4.4 63.7 1.0 C A:LEU113 4.4 35.8 1.0 CB A:VAL112 4.4 24.9 1.0 O A:HOH408 4.5 44.1 1.0 CA A:GLY114 4.5 46.9 1.0 N A:LEU113 4.5 26.6 1.0 CG2 A:THR111 4.6 27.0 1.0 CG A:GLU87 4.8 27.1 1.0 O A:LEU113 4.8 34.7 1.0 CA A:LEU113 4.8 31.3 1.0 O A:HOH422 4.9 62.8 1.0

P.Kazman, M.T.Vielberg, M.D.Pulido Cendales, L.Hunziger, B.Weber, U.Hegenbart, M.Zacharias, R.Kohler, S.Schonland, M.Groll, J.Buchner. Fatal Amyloid Formation in A Patient'S Antibody Light Chain Is Caused By A Single Point Mutation. Elife V. 9 2020.
ISSN: ESSN 2050-084X
PubMed: 32151314
DOI: 10.7554/ELIFE.52300